Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Total Non-Current Liabilities: 2009-2025

Historic Total Non-Current Liabilities for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Pediatrix Medical's Total Non-Current Liabilities fell 275.54% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 275.54%. This contributed to the annual value of $1.4 billion for FY2024, which is 109.52% up from last year.
  • Latest data reveals that Pediatrix Medical reported Total Non-Current Liabilities of $1.3 billion as of Q3 2025, which was down 275.54% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Total Non-Current Liabilities ranged from a high of $1.8 billion in Q4 2021 and a low of $1.2 billion during Q1 2025
  • Over the past 5 years, Pediatrix Medical's median Total Non-Current Liabilities value was $1.4 billion (recorded in 2024), while the average stood at $1.4 billion.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first tumbled by 3985.48% in 2021, then soared by 109.52% in 2024.
  • Pediatrix Medical's Total Non-Current Liabilities (Quarter) stood at $1.8 billion in 2021, then decreased by 20.56% to $1.4 billion in 2022, then fell by 5.41% to $1.3 billion in 2023, then rose by 1.1% to $1.4 billion in 2024, then dropped by 5.88% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.2 billion during Q1 2025.